Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Superficial lymphadenopathy

General symptoms · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: In first-contact care, the annual incidence of unexplained lymphadenopathy is 0.6% (US review citing a 1988 Dutch study) [1].

Cervical > 1 cm, acute onset < 3 weeks, with an identified cause (tonsillitis, dental infection, skin infection of the face or scalp)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Cervical > 1 cm: other situations (> 3 weeks OR no obvious cause identified OR local abnormalities, non-inflammatory nodes)

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Supraclavicular > 1 cm

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Axillary > 1 cm

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Epitrochlear

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Inguinal > 2 cm

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Preauricular (pretragal)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Occipital

Detailed explanation and international comparison (in French): read it in English (machine translation)

Generalised

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Child: localised non-inflammatory node, or generalised lymphadenopathy

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (13)
  1. Gaddey HL, Riegel AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2016;94(11):896-903.
  2. Perlat A, Grosbois B. Adénopathies superficielles. Principales causes : infectieuses, tumorales, inflammatoires ou auto-immunes. Rev Prat Med Gen 2015;29(941):384-385.
  3. Falk N, Joseph R, Dieujuste M. Lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2025;112(3):286-293.
  4. Cancer Council Victoria, Department of Health Victoria. Optimal care pathway for people with Hodgkin and diffuse large B-cell lymphomas, 2e édition, juin 2021 (Australie).
  5. Centre for Sustainable Delivery (NHS Scotland). Scottish referral guidelines for suspected cancer : Haematological cancers (Right Decision Service), consulté le 30 octobre 2026.
  6. Pynnonen MA, Gillespie MB, Roman B, et al. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Otolaryngol Head Neck Surg 2017;157(2_suppl):S1-S30 (American Academy of Otolaryngology-Head and Neck Surgery Foundation).
  7. Papo T. Adénopathie superficielle. EMC - Traité de Médecine Akos 2020;23(2):1-5 [Article 1-0180]. Cité à titre exceptionnel (décision des auteurs du 24/10/2026, point 9), faute de source primaire équivalente.
  8. Pilly : adénopathies superficielles (2023)
  9. Pas-à-pas en pédiatrie : adénopathies superficielles.
  10. Dufour I, Verstraete G, Raedemaeker J, Andreozzi F, Bailly S, Van Den Neste E, Hermans C, Vekemans M-C. Bilan d’adénopathie en médecine générale : quand rassurer et quand référer ? Louvain Med 2022;141(3):162-167.
  11. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral (NG12). Publiée le 23 juin 2015, dernière mise à jour le 15 avril 2026. Section 1.10.
  12. Collège national des pédiatres universitaires (CNPU). Référentiel de pédiatrie, chapitre 25 – Item 220 : Adénopathies superficielles.
  13. Gaddey HL, Riegel AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician 2016;94(11):896-903.